Tobacco assessment in completed lung cancer treatment trials
Cancer
.
2016 Nov 15;122(21):3260-3262.
doi: 10.1002/cncr.30223.
Epub 2016 Jul 26.
Authors
Erica N Peters
1
2
3
,
Graham W Warren
4
,
Jeff A Sloan
5
,
James R Marshall
6
Affiliations
1
Battelle Public Health Center for Tobacco Research, Baltimore, Maryland. finan@battelle.org.
2
Department of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York. finan@battelle.org.
3
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut. finan@battelle.org.
4
Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.
5
Research Faculty, Mayo Clinic, Rochester, Minnesota.
6
Department of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York.
PMID:
27459400
PMCID:
PMC5338464
DOI:
10.1002/cncr.30223
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Lung Neoplasms / etiology*
Lung Neoplasms / therapy
Nicotiana
Smoking / adverse effects*
Smoking Cessation
Grants and funding
U10 CA180867/CA/NCI NIH HHS/United States
UG1 CA189823/CA/NCI NIH HHS/United States